1. Home
  2. NVAX vs XMTR Comparison

NVAX vs XMTR Comparison

Compare NVAX & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • XMTR
  • Stock Information
  • Founded
  • NVAX 1987
  • XMTR 2013
  • Country
  • NVAX United States
  • XMTR United States
  • Employees
  • NVAX N/A
  • XMTR N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • XMTR Industrial Machinery/Components
  • Sector
  • NVAX Health Care
  • XMTR Technology
  • Exchange
  • NVAX Nasdaq
  • XMTR Nasdaq
  • Market Cap
  • NVAX 1.3B
  • XMTR 1.2B
  • IPO Year
  • NVAX 1995
  • XMTR 2021
  • Fundamental
  • Price
  • NVAX $6.00
  • XMTR $22.04
  • Analyst Decision
  • NVAX Buy
  • XMTR Buy
  • Analyst Count
  • NVAX 6
  • XMTR 10
  • Target Price
  • NVAX $17.83
  • XMTR $34.60
  • AVG Volume (30 Days)
  • NVAX 6.0M
  • XMTR 655.4K
  • Earning Date
  • NVAX 05-09-2025
  • XMTR 05-08-2025
  • Dividend Yield
  • NVAX N/A
  • XMTR N/A
  • EPS Growth
  • NVAX N/A
  • XMTR N/A
  • EPS
  • NVAX N/A
  • XMTR N/A
  • Revenue
  • NVAX $682,162,000.00
  • XMTR $545,529,000.00
  • Revenue This Year
  • NVAX $1.07
  • XMTR $21.02
  • Revenue Next Year
  • NVAX N/A
  • XMTR $17.27
  • P/E Ratio
  • NVAX N/A
  • XMTR N/A
  • Revenue Growth
  • NVAX N/A
  • XMTR 17.72
  • 52 Week Low
  • NVAX $3.81
  • XMTR $11.08
  • 52 Week High
  • NVAX $23.86
  • XMTR $45.33
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 41.41
  • XMTR 42.19
  • Support Level
  • NVAX $5.01
  • XMTR $20.95
  • Resistance Level
  • NVAX $6.58
  • XMTR $22.21
  • Average True Range (ATR)
  • NVAX 0.65
  • XMTR 1.84
  • MACD
  • NVAX 0.02
  • XMTR 0.17
  • Stochastic Oscillator
  • NVAX 50.25
  • XMTR 49.64

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.

Share on Social Networks: